Wednesday's HotCopper trends: Race RC220 doses, West Mits Qala study | July 23
Race Oncology (ASX:RAC) has captured the most attention on the HotCopper forums today after successfully @ and safely @ dosing its first patient with RC220 and RC220 in combination with doxorubicin.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines ...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RPC | re-instatement | 10/07/09 | 6 | 2.0K | |||
|
|||||||
RPC | set to do well | 10/07/09 | 0 | 452 | |||
|
|||||||
RPC | Ann: Shareholder Activity Update | 10/07/09 | 0 | 647 | |||
|
|||||||
RPC | Ann: Amended ASX Circular | 10/07/09 | 0 | 482 | |||
|
|||||||
RPC | Ann: Quoted Options Top 20 | 09/07/09 | 0 | 465 | |||
|
|||||||
RPC | Ann: Fully Paid Ordinary Shares Top 20 | 09/07/09 | 0 | 553 | |||
|
|||||||
RPC | Ann: Ceasing to be a substantial holder | 09/07/09 | 0 | 434 | |||
|
|||||||
RPC | Ann: Becoming a substantial holder | 09/07/09 | 0 | 487 | |||
|
See All Discussions